Drug intelligence / Profile preview

P60

Development stage
Preclinical
Lead developer
Cima Universidad de Navarra
Modality
Peptides
Administration
Intratumoral, Peritumoral
01

Overview

P60 is a synthetic 15-mer peptide designed to inhibit the function of Forkhead box P3 (Foxp3), a transcription factor essential for the development and suppressive function of regulatory T cells (Tregs). In the tumor microenvironment, Tregs impair the efficacy of cancer immunotherapies by suppressing antitumor immune responses. P60 enters cells and binds to Foxp3, interfering with its nuclear translocation and its ability to associate with transcription factors such as NF-κB and NFAT. Beyond its effect on Tregs, P60 has been shown to directly inhibit Foxp3-expressing tumor cells, reducing the secretion of immunosuppressive cytokines like IL-10. Developed largely within academic research settings, it has demonstrated potential as both a monotherapy and an adjuvant to boost the efficacy of dendritic cell vaccines in preclinical models of breast cancer.

Other names
Foxp3 inhibitor peptide P60Foxp-3 inhibitor peptide P60Foxp 3 inhibitor peptide P60P60 peptideP-60 peptideP 60 peptide
02

Targets

FOXP3 (Forkhead box protein P3)

Beyond the preview

Go deeper on P60.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on P60.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call